Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/gim.2017.166 http://scihub22266oqcxt.onion/10.1038/gim.2017.166 C5908763!5908763!29048417     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Genet+Med 2018 ; 20 (7): 737-44 Nephropedia Template TP {{tp|p=29048417|t=2018. Pathways from Autism Spectrum Disorder (ASD) Diagnosis to Genetic Testing |pdf=|usr=}}{{29048417}} gab.com Text Pathways from Autism Spectrum Disorder (ASD) Diagnosis to Genetic Testing JO: Genet Med http://www.kidney.de/pget.php?&tw=1&pmid=29048417 #FOAvip Purpose: This study examines challenges faced by families and health providers related to genetic testing for autism spectrum disorder (ASD). Methods: This qualitative study of 14 parents and 15 health providers identified an unstandardized three-step process for families who pursue ASD genetic testing. Results: Step 1 is the clinical diagnosis of ASD, confirmed by providers practicing alone or in a team. Step 2 is the offer of genetic testing to find an etiology. For those offered testing, step 3 involves the parents? decision whether to pursue testing. Despite professional guidelines and recommendations, interviews describe considerable variability in approaches to genetic testing for ASD, a lack of consensus among providers, and questions about clinical utility. Many families in our study were unaware of the option for genetic testing; testing decisions by parents appear to be influenced by both provider recommendations and insurance coverage. Conclusion: Consideration of genetic testing for ASD should take into account different views about the clinical utility of testing and variability in insurance coverage. Ideally, policy makers from the range of clinical specialties involved in ASD care should revisit policies to clarify the purpose of genetic testing for ASD and promote consensus about its appropriate use. Twit Text FOAVip Pathways from Autism Spectrum Disorder (ASD) Diagnosis to Genetic Testing ????Genet Med http://www.kidney.de/pget.php?&tw=1&pmid=29048417 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29048417 #FOAvip English Wikipedia <ref>{{Cite pmid|29048417}}</ref> Pathways from Autism Spectrum Disorder (ASD) Diagnosis to Genetic Testing #MMPMID29048417 Barton KS; Tabor HK; Starks H; Garrison NA; Laurino M; Burke W Genet Med 2018[Jul]; 20 (7): 737-44 PMID29048417show ga Purpose: This study examines challenges faced by families and health providers related to genetic testing for autism spectrum disorder (ASD). Methods: This qualitative study of 14 parents and 15 health providers identified an unstandardized three-step process for families who pursue ASD genetic testing. Results: Step 1 is the clinical diagnosis of ASD, confirmed by providers practicing alone or in a team. Step 2 is the offer of genetic testing to find an etiology. For those offered testing, step 3 involves the parents? decision whether to pursue testing. Despite professional guidelines and recommendations, interviews describe considerable variability in approaches to genetic testing for ASD, a lack of consensus among providers, and questions about clinical utility. Many families in our study were unaware of the option for genetic testing; testing decisions by parents appear to be influenced by both provider recommendations and insurance coverage. Conclusion: Consideration of genetic testing for ASD should take into account different views about the clinical utility of testing and variability in insurance coverage. Ideally, policy makers from the range of clinical specialties involved in ASD care should revisit policies to clarify the purpose of genetic testing for ASD and promote consensus about its appropriate use. äPathways from Autism Spectrum Disorder (ASD) Diagnosis to Genetic Test(epmc).pdf DeepDyve Pubget Overpricing